Early intervention: Which patients and how early?

Current Cardiology Reports

Volumn 10, Issue 4, 2008, Pages 303-311

  Brennan, J Matthew ^a   Petersen, John L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; RETEPLASE; STREPTOKINASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ALGORITHM; ANGIOCARDIOGRAPHY; BALLOON DILATATION; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMORBIDITY; CONSERVATIVE TREATMENT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG MEGADOSE; EARLY INTERVENTION; ELECTROCARDIOGRAPHY; EMERGENCY SURGERY; FEASIBILITY STUDY; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MORBIDITY; MORTALITY; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; RISK REDUCTION; ST SEGMENT ELEVATION; SYMPTOM; THERAPY DELAY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS; ARTICLE; HEART MUSCLE REVASCULARIZATION; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; TIME;

ACUTE CORONARY SYNDROME; ALGORITHMS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 54449088330     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-008-0049-6     Document Type: Review

References (50)

1. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB: The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977, 56: 786-794.
2. Zipes DP, Braunwald E: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, edn 7. Philadelphia: Elsevier Saunders; 2005.
3. Vargas SO, Sampson BA, Schoen FJ: Pathologic detection of early myocardial infarction: A critical review of the evolution and usefulness of modern techniques. Mod Pathol 1999, 12: 635-645.
4. Reynolds HR, Cochman JS: Cardiogenic shock: current concepts and improving outcomes. Circulation 2008, 117: 686-697.
5. Babaev A, Frederick PD, Pasta DJ, et al.: Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005, 294: 448-454.
6. Fox KA, Steg PG, Eagle KA, et al.: Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007, 297: 1892-1900.
7. Eagle KA, Lim MJ, Dabbous OH, et al.: A validated prediction model for all forms of acute coronary syndrome: Estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004, 291: 2727-2733.
8. Reiner JS, Lundergan CF, van den Brand M, et al.: Early angiography cannot predict postthrombolytic coronary reocclusion: Observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol 1994, 24: 1439-1444.
9. Simes RJ, Topol EJ, Holmes DR Jr, et al.: Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation 1995, 91: 1923-1928.
10. van't Hof AW, Liem A, Suryapranata H, et al.: Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998, 97: 2302-2306.
11. de Lemos JA, Morrow DA, Gibson CM, et al.: Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardiol 2001, 88: 353-358.
12. Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, et al.: Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: A meta-analysis of randomized trials. J Am Coll Cardiol 2007, 49: 422-430.
13. Sutton AG, Campbell PG, Graham R, et al.: A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: The Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol 2004, 44: 287-296.
14. Gershlick AH, Stephens-Lloyd A, Hughes S, et al.: Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005, 353: 2758-2768.
15. Antman EM, Anbe DT, Armstrong PW, et al.: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004, 44: 671-719.
16. Cantor WJ, Fitchett D, Borgundvaag B, et al.: Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI). Presented at the American College of Cardiology 57th Scientific Sessions. Chicago, IL; March 29-April 1, 2008.
17. Keeley EC, Boura JA, Grines CL: Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003, 361: 13-20.
18. Hochman JS, Sleeper LA, Webb JG, et al.: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? N Engl J Med 1999, 341: 625-634.
19. Wu AH, Parsons L, Every NR, Bates ER: Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002, 40: 1389-1394.
20. Stone GW, Grines CL, Browne KF, et al.: Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol 1996, 78: 19-25.
21. van't Hof AW, Ottervanger JP: No mortality benefit of primary angioplasty over thrombolytic therapy in patients with nonanterior myocardial infarction at long-term follow-up: Results of the Zwolle trial [abstract]. J Am Coll Cardiol 2003, 41: 369A.
22. Berger PB, Ellis SG, Holmes DR Jr, et al.: Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: Results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999, 100: 14-20.
23. Widimsky P, Budesinsky T, Vorac D, et al.: Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial - PRAGUE-2. Eur Heart J 2003, 24: 94-104.
24. Jollis JG, Roettig ML, Aluko AO, et al.: Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA 2007, 298: 2371-2380.
25. Ferguson JD, Brady WJ, Perron AD, et al.: The prehospital 12-lead electrocardiogram: Impact on management of the out-of-hospital acute coronary syndrome patient. Am J Emerg Med 2003, 21: 136-142.
26. Nallamothu BK, Bates ER, Herrin J, et al.: Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005, 111: 761-777.
27. Ellis SJ: Facilitated Intervention with enhanced reperfusion speed to stop events (FINESSE). Presented at the European Society of Cardiology 2007 Scientific Sessions. Vienna, Austria; September 1-5, 2007.
28. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators: Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomised trial. Lancet 2006, 367: 569-578.
29. Montalescot G, Barragan P, Wittenberg O, et al.: Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001, 344: 1895-1903.
30. van't Hof A, Hamm CW, ten Berg JM, et al.: Ongoing Tirofiban in Myocardial Infarction Evaluation (ONTIME 2) trial. Presented at the American College of Cardiology 57th Scientific Sessions 2008, Chicago, IL; March 29-April 1, 2008.
31. Rosamond W, Flegal K, Furie K, et al.: Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117: E25-e146.
32. Thygesen K, Alpert JS, White HD: Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50: 2173-2195.
33. Roe MT, Chen AY, Mehta RH, et al.: Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes. Circulation 2007, 116: 1153-1161.
34. Shah BR, Glickman SW, Liang L, et al.: The impact of forprofit hospital status on the care and outcomes of patients with non-ST-segment elevation myocardial infarction: Results from the CRUSADE Initiative. J Am Coll Cardiol 2007, 50: 1462-1468.
35. Antman EM, Cohen M, Bernink PJ, et al.: The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000, 284: 835-842.
36. Boersma E, Pieper KS, Steyerberg EW, et al.: Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000, 101: 2557-2567.
37. Granger CB, Goldberg RJ, Dabbous O, et al.: Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163: 2345-2353.
38. de Araujo Goncalves P, Ferreira J, Aguiar C, Seabra-Gomes R: TIMI, PURSUIT, and GRACE risk scores: Sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J 2005, 26: 865-872.
39. Yan AT, Jong P, Yan RT, et al.: Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndrome. Am Heart J 2004, 148: 1020-1027.
40. Yan AT, Yan RT, Tan M, et al.: Risk scores for risk stratification in acute coronary syndromes: Useful but simpler is not necessarily better. Eur Heart J 2007, 28: 1072-1078.
41. Anderson JL, Adams CD, Antman EM, et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50: E1-e157.
42. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators [no authors listed]. Lancet 1999, 354: 708-715.
43. Cannon CP, Weintraub WS, Demopoulos LA, et al.: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001, 344: 1879-1887.
44. Fox KA, Poole-Wilson PA, Henderson RA, et al.: Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: The British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002, 360: 743-751.
45. Spacek R, Widimsky P, Straka Z, et al.: Value of first day angiography/ angioplasty in evolving non-ST segment elevation myocardial infarction: an open multicenter randomized trial. The VINO Study. Eur Heart J 2002, 23: 230-238.
46. de Winter RJ, Windhausen F, Cornel JH, et al.: Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 2005, 353: 1095-1104.
47. Bavry AA, Kumbhani DJ, Rassi AN, et al.: Benefit of early invasive therapy in acute coronary syndromes: A meta-analysis of contemporary randomized clinical trials. J Am Coll Cardiol 2006, 48: 1319-1325.
48. Hoenig MR, Doust JA, Aroney CN, Scott IA: Early invasive versus conservative strategies for unstable angina and non-ST-elevation myocardial infarction in the stent era. Cochrane Database Syst Rev 2006, 3: CD004815.
49. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al.: Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: A randomized controlled trial. JAMA 2003, 290: 1593-1599.
50. Tricoci P, Lokhnygina Y, Berdan LG, et al.: Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: Results from the SYNERGY trial. Circulation 2007, 116: 2669-2677.